News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
Industry update Pot product manufacturer Valens bounces back in Q1 The Canadian cannabis extractor touts manufacturing strategy as Q1 sales jump 25% to $20M Jared GnamApril 15, 2021
Industry update Valens bullish on manufacturing strategy despite Q4 sales drop Despite an 11.6% drop in revenue, the Canadian cannabis extractor says domestic manufacturing expansion will boost sales this year Jared GnamFebruary 25, 2021